Fingerprint
Dive into the research topics of 'Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas
Margaret Von Mehren, Cathryn Rankin, John R. Goldblum, George D. Demetri, Vivien Bramwell, Christopher W. Ryan, Ernest Borden
Research output: Contribution to journal › Article › peer-review
94
Scopus
citations